Identification of nestin as a urinary biomarker for acute kidney injury

American Journal of Nephrology

Volumn 39, Issue 2, 2014, Pages 110-121

  Zhang, Wen ^a   Zhang, Lu ^a   Chen, Yong Xi ^a   Xie, Yin Yin ^c   Zou, Yan Fang ^a   Zhang, Ming Jun ^a   Gao, Yao Hui ^c   Liu, Yue ^b   Zhao, Qiang ^a   Huang, Qiu Hua ^c   Chen, Nan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c Department of Science and Education MingHang Central Hospital   (China)

Author keywords

Acute kidney injury; Nestin; Urinary biomarker

Indexed keywords

BIOLOGICAL MARKER; CISPLATIN; CREATININE; FETUIN A; HAMARTIN; KININOGEN; NESTIN; PROTEIN P53; T KININOGEN; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS; HUMAN; HUMAN CELL; KIDNEY ISCHEMIA; KIDNEY TUBULE CELL; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MIDDLE AGED; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; URINALYSIS; WESTERN BLOTTING; YOUNG ADULT; CELL HYPOXIA; COMPARATIVE STUDY; CREATININE BLOOD LEVEL; GENE SILENCING; KIDNEY INJURY; NESTIN URINE LEVEL; POSTOPERATIVE PERIOD; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN URINE LEVEL; PROTEOMICS; UREA NITROGEN BLOOD LEVEL;

ACUTE KIDNEY INJURY; ADULT; AGED; ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; CISPLATIN; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NESTIN; POSTOPERATIVE COMPLICATIONS; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84893648978     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000358260     Document Type: Article

References (34)

1. Mehta RL, Kellum JA, Shah SV, et al: Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11:R31.
2. Bellomo R, Ronco C, Kellum JA, et al: Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8:R204-R212.
3. Kellum JA: Acute kidney injury. Crit Care Med 2008; 36(suppl):S141-S145.
4. Zhang W, Shen PY, Chen YX, et al: Analyzing Chinese patients with post-operative acute kidney injury. Ren Fail 2011; 33: 795-800.
5. Ympa YP, Sakr Y, Reinhart K, et al: Has mortality from acute renal failure decreased? A systematic review of the literature. Am J Med 2005; 118: 827-832.
6. Waikar SS, Curhan GC, Wald R, et al: Declining mortality in patients with acute renal failure, 1988-2002. J Am Soc Nephrol 2006; 17: 1143-1150.
7. Khwaja A: KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Nephron Clin Pract 2012; 120: 179-184.
8. Hewitt SM, Dear J, Star RA: Discovery of protein biomarkers for renal diseases. J Am Soc Nephrol 2004; 15: 1677-1689.
9. Herget-Rosenthal S, Marggraf G, Husing J, et al: Early detection of acute renal failure by serum cystatin C. Kidney Int 2004; 66: 1115-1122.
10. Devarajan P: Update on mechanisms of isch-emic acute kidney injury. J Am Soc Nephrol 2006; 17: 1503-1520.
11. Reeves WB, Kwon O, Ramesh G. Netrin-1 and kidney injury. II. Netrin-1 is an early bio-marker of acute kidney injury. Am J Physiol Renal Physiol 2008; 294:F731-F738.
12. 1-induced epithelial-to-mesenchymal transition. Am J Nephrol 2010; 31: 24-35.
13. Wang J, Biju MP, Wang MH, et al: Cytopro-tective effects of hypoxia against cisplatin-in-duced tubular cell apoptosis: involvement of mitochondrial inhibition and p53 suppression. J Am Soc Nephrol 2006; 17: 1875-1885.
14. Devarajan P: Proteomics for biomarker discovery in acute kidney injury. Semin Nephrol 2007; 27: 637-651.
15. Mann M: Quantitative proteomics? Nat Bio-technol 1999; 17: 954-955.
16. Wu WW, Wang G, Baek SJ, et al: Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel-or LC-MALDI TOF/TOF. J Proteome Res 2006; 5: 651-658.
17. Ross PL, Huang YN, Marchese JN, et al: Multiplexed protein quantitation in Saccharomy-ces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 2004; 3: 1154-1169.
18. 2-Heremans-Schmid glycopro-tein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003; 112: 357-366.
19. Pecovnik-Balon B: Cardiovascular calcification in patients with end-stage renal disease. Ther Apher Dial 2005; 9: 208-210.
20. Ketteler M, Bongartz P, Westenfeld R, et al: Association of low fetuin-A concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003; 361: 827-833.
21. Stefan N, Hennige AM, Staiger H, et al: Al-pha-2-Heremans-Schmid glycoprotein/fe-tuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 2006; 29: 853-857.
22. Mori K, Emoto M, Yokoyama H, et al: Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects. Diabetes Care 2006; 29: 468.
23. Zhou H, Pisitkun T, Aponte A, et al: Exosom-al fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury. Kidney Int 2006; 70: 1847-1857.
24. Yoon KH, Yoon M, Moir RD, et al: Insights into the dynamic properties of keratin intermediate filaments in living epithelial cells. J Cell Biol 2001; 153: 503-516.
25. Goldman RD: Worms reveal essential functions for intermediate filaments. Proc Natl Acad Sci USA 2001; 98: 7659-7661.
26. Michalczyk K, Ziman M: Nestin structure and predicted function in cellular cytoskeletal organisation. Histol Histopathol 2005; 20: 665-671.
27. Chen J, Boyle S, Zhao M, et al: Differential expression of the intermediate filament protein nestin during renal development and its localization in adult podocytes. J Am Soc Nephrol 2006; 17: 1283-1291.
28. Zou J, Yaoita E, Watanabe Y, et al: Upregula-tion of nestin, vimentin, and desmin in rat podocytes in response to injury. Virchows Arch 2006; 448: 485-492.
29. Vansthertem D, Gossiaux A, Decleves AE, et al: Expression of nestin, vimentin, and NCAM by renal interstitial cells after ischemic tubular injury. J Biomed Biotechnol 2010; 2010: 193259.
30. Daniel C, Albrecht H, Ludke A, et al: Nestin expression in repopulating mesangial cells promotes their proliferation. Lab Invest 2008; 88: 387-397.
31. Liu W, Zhang Y, Liu S, et al: The expression of intermediate filament protein nestin and its association with cyclin-dependent kinase 5 in the glomeruli of rats with diabetic nephropa-thy. Am J Med Sci 2013; 345: 470-477.
32. Lee JH, Kim HS, Lee SJ, et al: Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death. J Cell Sci 2007; 120: 2259-2271.
33. Thorner PS, Ho M, Eremina V, et al: Podo-cytes contribute to the formation of glomeru-lar crescents. J Am Soc Nephrol 2008; 19: 495-502.
34. Tomioka M, Hiromura K, Sakairi T, et al: Nestin is a novel marker for renal tubuloin-terstitial injury in immunoglobulin A ne-phropathy. Nephrology (Carlton) 2010; 15: 568-574.